Proton beam therapy and iris neovascularisation in uveal melanoma

被引:16
|
作者
Boyd, S. R.
Gittos, A.
Richter, M.
Hungerford, J. L.
Errington, R. D.
Cree, I. A. [1 ]
机构
[1] Alexandra Hosp, Translat Oncol Res Ctr, Dept Histopathol, Michael Darmady Lab, Portsmouth PO6 3LY, Hants, England
[2] UCL, Dept Pathol, Inst Ophthalmol, London, England
[3] Univ Toronto, Dept Ophthalmol, St Michaels Hosp, Toronto, ON M5B 1W8, Canada
[4] Univ Toronto, Vasc Biol Res Grp, St Michaels Hosp, Toronto, ON M5B 1W8, Canada
[5] Moorfields Eye Hosp, London, England
[6] Univ Med Berlin, Ophthalm Clin, Berlin, Germany
[7] Clatterbridge Ctr Oncol, Wirral, Merseyside, England
关键词
iris; angiogenesis; glaucoma; melanoma; proton; irradiation;
D O I
10.1038/sj.eye.6702072
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose Local treatment of uveal melanoma by radiotherapy involves the use of brachytherapy with radioactive plaques attached to the sclera, or proton irradiation. Both treatments induce growth arrest within the tumour and its slow involution over several years. Although ocular retention rates are excellent, regrowth of tumours due to resistance and neovascular glaucoma leads to enucleation of up to 10% of affected eyes. Proton irradiation involves part of the iris in most cases and we noticed that neovascularisation only occurred in the part of the iris that was not irradiated. We therefore conducted this study to determine the relationship between the development of iris neovascularisation and iris irradiation. Methods A total of 21 enucleation specimens from patients who had previously had proton irradiation were collected from the files of the Department of Pathology, Moorfields Eye Hospital during the 5-year period from 1994 to 1999. Sections of these eyes were assessed for VEGF-A, bFGF, and von Willebrand Factor (vWF) by immunohistochemistry. Ophthalmic notes and radiotherapy records were reviewed to assess the extent of iris irradiation. Results In all, 11 cases showed clinical evidence of iris neovascularisation and were selected for further study. Three of these eyes also showed clinical evidence of regrowth of the tumour. Histological evidence of iris neovascularization was noted in all 11 of the eyes examined, and was only present in the nonirradiated side of the iris in 8/11 eyes. NVI was present on both sides of the iris in three cases, but was less severe in the irradiated part. Expression of VEGF-A was at most weak within the tumour, but was present in the detached retina and in the epithelium of both ciliary body and iris. Some bFGF staining was noted around vessels in the iris stroma. Conclusions Our results suggest that irradiation leads to iris atrophy, and that atrophic, irradiated iris is resistant to the development of neovascularisation.
引用
收藏
页码:832 / 836
页数:5
相关论文
共 50 条
  • [31] Intravitreal bevacizumab for neovascular glaucoma in uveal melanoma treated by proton beam therapy
    Mahdjoubi, Amir
    Najean, Marie
    Lemaitre, Stephanie
    Dureau, Sylvain
    Dendale, Remi
    Levy, Christine
    Lumbroso-Le Rouic, Livia
    Desjardins, Laurence
    Cassoux, Nathalie
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2018, 256 (02) : 411 - 420
  • [32] Salvage proton beam therapy for recurrent iris melanoma: outcome and side effects
    Aline I. Riechardt
    Julian P. Klein
    Dino Cordini
    Jens Heufelder
    Matus Rehak
    Ira Seibel
    Antonia M. Joussen
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2018, 256 : 1325 - 1332
  • [33] Salvage proton beam therapy for recurrent iris melanoma: outcome and side effects
    Riechardt, Aline I.
    Klein, Julian P.
    Cordini, Dino
    Heufelder, Jens
    Rehak, Matus
    Seibel, Ira
    Joussen, Antonia M.
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2018, 256 (07) : 1325 - 1332
  • [34] Photodynamic therapy for recurrent hyphema after proton beam radiotherapy of iris melanoma
    Nikolaos Trichopoulos
    Bertil Damato
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2007, 245 : 1573 - 1575
  • [35] Photodynamic therapy for recurrent hyphema after proton beam radiotherapy of iris melanoma
    Trichopoulos, Nikolaos
    Damato, Bertil
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2007, 245 (10) : 1573 - 1575
  • [36] Scleritis after Proton Therapy in Uveal Melanoma
    Passarin, O.
    Zografos, L.
    Schalenbourg, A.
    Moulin, A.
    Guex-Crosier, Y.
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2012, 229 (04) : 395 - 398
  • [37] Uveal melanoma clonogenic response to proton beam irradiation
    Dixon, B. Romanowska
    Jasinska, K.
    Michalik, M.
    Madeja, Z.
    Urbanska, K.
    Elas, M.
    ACTA OPHTHALMOLOGICA, 2016, 94
  • [39] Proton beam therapy for iris melanomas
    L Lumbroso-Le Rouic
    S Delacroix
    R Dendale
    C Levy-Gabriel
    L Feuvret
    G Noel
    C Plancher
    C Nauraye
    P Garcia
    V Calugaru
    B Asselain
    L Desjardins
    Eye, 2006, 20 : 1300 - 1305
  • [40] CONSERVATIVE TREATMENT OF UVEAL MELANOMA - LOCAL RECURRENCE AFTER PROTON-BEAM THERAPY
    MUNZENRIDER, JE
    VERHEY, LJ
    GRAGOUDAS, ES
    SEDDON, JM
    URIE, M
    GENTRY, R
    BIRNBAUM, S
    RUOTOLO, DM
    CROWELL, C
    MCMANUS, P
    FINN, S
    SISTERSON, J
    JOHNSON, K
    EGAN, K
    LENTO, D
    BASSIN, P
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1989, 17 (03): : 493 - 498